We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Role of the Human Serum Albumin Protein Corona in the Antimicrobial and Photothermal Activity of Metallic Nanoparticles against <i>Escherichia coli</i> Bacteria
Summary
Researchers studied how a protein coating that forms on metal nanoparticles in biological fluids affects their ability to kill bacteria. They found that a human serum albumin corona reduced the antimicrobial effectiveness of platinum and silver nanoparticles but enhanced the photothermal bacteria-killing ability of gold nanoparticles. The findings are relevant for understanding how nanoparticles behave in real biological environments, which differs from controlled laboratory conditions.
The emergence of antibiotic-resistant bacteria has become a major public health concern, leading to growing interest in alternative antimicrobial agents. The antibacterial activity of metal nanoparticles (NPs) has been extensively studied, showing that they can effectively inhibit the growth of various bacteria, including both Gram-positive and -negative strains. The presence of a protein corona, formed by the adsorption of proteins onto the NP surface in biological fluids, can significantly affect their toxicity. Understanding the effect of the protein corona on the antimicrobial activity of metal NPs is crucial for their effective use as antimicrobial agents. In this study, the antimicrobial activity of noble metal NPs, such as platinum (Pt), silver (Ag), and gold (Au) with and without the human serum albumin (HSA) protein corona against <i>Escherichia coli</i> strains, was investigated. In addition, the plasmonic photothermal effect related to AuNPs, which resulted to be the most biocompatible compared to the other considered metals, was evaluated. The obtained results suggest that the HSA protein corona modulated the antimicrobial activity exerted by the metal NPs against <i>E. coli</i> bacteria. These findings may pave the way for the investigation and development of innovative nanoapproaches to face antibiotic resistance emergence.
Sign in to start a discussion.